Overview
Weihong Qiu practices in Fuzhou, China. Their top areas of expertise are Splenic Infarction, Non-Alcoholic Fatty Liver Disease, COVID-19, and Metabolic Syndrome.
Their clinical research consists of co-authoring 47 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Qiu isExperienced. Learn about COVID-19.
- Lung MetastasesQiu isExperienced. Learn about Lung Metastases.
- Metabolic SyndromeQiu isExperienced. Learn about Metabolic Syndrome.
- Non-Alcoholic Fatty Liver Disease
- PneumoniaQiu isExperienced. Learn about Pneumonia.
- Splenic InfarctionQiu isExperienced. Learn about Splenic Infarction.